Ticker Details
MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.
IPO Date:	March 1, 2008
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$634.51M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 2.84%
Avg Daily Range (30 D):	$0.06 | 1.58%
Avg Daily Range (90 D):	$0.08 | 2.05%

Institutional Daily Volume
Avg Daily Volume:	.56M
Avg Daily Volume (30 D):	.96M
Avg Daily Volume (90 D):	1.1M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	119

Institutional Trades
Total Institutional Trades:	2,188
Avg Institutional Trade:	$1.38M
Avg Institutional Trade (30 D):	$1.37M
Avg Institutional Trade (90 D):	$1.18M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.45M
Avg Closing Trade (30 D):	$1.35M
Avg Closing Trade (90 D):	$1.12M
Avg Closing Volume:	181.79K

News

Feb 17, 2026 @ 1:00 PM MIMEDX to Host Fourth Quarter and Full Year 2025 O... Source: Na

Feb 2, 2026 @ 1:00 PM MIMEDX Celebrates 15 Year Anniversary of EPIFIXÂÂ... Source: Mimedx Group, Inc.

Oct 15, 2025 @ 12:00 PM MIMEDX to Host Third Quarter 2025 Operating and Fi... Source: Matt Notarianni

Sep 3, 2025 @ 12:00 PM MIMEDX to Sponsor and Attend Symposium on Advanced... Source: Matt Notarianni

Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.07		$.33
Diluted EPS	$-.07		$.32
Revenue	$58.99M		$418.63M
Gross Profit	$41.62M		$345.62M
Net Income / Loss	$-10.86M		$48.58M
Operating Income / Loss	$-16.05M		$63.89M
Cost of Revenue	$17.37M		$73.01M
Net Cash Flow	$-6.35M		$61.71M
PE Ratio

Splits
Apr 02, 2008	11:34